Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: Plasma and saliva analysis

Eric T. Moolchan, Edward J. Cone, Abraham Wstadik, Marilyn A. Huestis, Kenzie L. Preston

Research output: Contribution to journalArticle

Abstract

Several reports suggest a prolonged elimination of cocaine and metabolites after chronic use compared with single or occasional use. This study was designed to measure the half-lives of cocaine in plasma and saliva of individuals who consumed cocaine on a frequent basis. The disposition and elimination patterns of cocaine and metabolites in the body fluids of chronic high-dose cocaine users during acute cessation of use were investigated. Plasma and saliva specimens were collected over a 12-h period during cessation and analyzed by gas chromatography-mass spectrometry. Pharmacokinetic parameters were derived by noncompartmental analysis of plasma and saliva data. Results indicated a cocaine terminal T( 1/2 ) of 3.8 h in plasma and 7.9 h in saliva. The terminal T( 1/2 ) of benzoylecgonine was 6.6 h in plasma and 9.2 h in saliva. Compared with prior studies of acute low-dose cocaine administration, these findings suggest that cocaine's half-life is longer in active street users than in occasional users though the half-life of its main metabolite benzoylecgonine remains similar (as do cocaine saliva-to-plasma ratios). Thus, regular use of cocaine appears to alter the disposition and elimination of cocaine when compared to single or occasional use.

Original languageEnglish (US)
Pages (from-to)458-466
Number of pages9
JournalJournal of analytical toxicology
Volume24
Issue number7
DOIs
StatePublished - Jan 1 2000

ASJC Scopus subject areas

  • Analytical Chemistry
  • Environmental Chemistry
  • Toxicology
  • Health, Toxicology and Mutagenesis
  • Chemical Health and Safety

Fingerprint Dive into the research topics of 'Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: Plasma and saliva analysis'. Together they form a unique fingerprint.

  • Cite this